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Cytogenetic Studies in Lymphocytes of
Patients with Rectal Cancer
by E. Gebhart,' R. Romahn,1 A. Schneider,
M. Hoffmann,' D. Rau,' and H. Tittelbachl
Spontaneous and clastogen-induced chromosomal instability in a high-risk group (i.e., 33 patients with
rectal carcinomas) was investigated using peripheral blood lymphocytes as target cells. In addition to the
analysis of spontaneous and clastogen-induced chromosome aberrations, this study also included classical
karyotype analysis and scoring ofsister chromatid exchanges (SCE) in some ofthe patients. Diepoxybutane
(DEB), 4-nitroquinoline-1-oxide (NQO), and bleomycin were used as standard clastogens. Lymphocytes of
healthy control individuals were studied inparallelwitheachcancerpatient.Whileonlyslightbutsignificant
differences could be detected of the average spontaneous, DEB- and bleomycin (G2)-induced chromosome
breakage between patient and control lymphocytes, individual patients and two of the control individuals
showed a more distinct increase in the frequency ofthe studied endpoints. These increases were documented
byavariegated mosaicism ofkaryotypicchangesandbyanincreasedbreakage rate inducedbytheclastogens.
Neither the bleomycin-exposure in the G, phase nor SCE was capable of detecting differences between the
patients and controls. Ofparticular interest in the sense ofhigh-risk individuals were seven patients and two
control persons whose lymphocytes exhibited increased chromosomal sensitivity under more than one ofthe
studied experimental conditions.
Introduction
On the cellular level, the process ofmalignant transfor-
mation is caused by a complex series of genetic changes
(mutations). Incontrasttoprevious assumptions, thebasic
role ofthese mutational events is not restricted to the so-
calledinitiationphase,butisequallyrelevantinpromotion,
transformation, tumor progression, and metastasis (1-7).
Frequency and order of the mutational events may vary
from neoplasia to neoplasia, but their presence is inti-
mately involved in oncogenesis.
Early in the development of tumor cytogenetics, a spe-
cific type ofhuman genetic disease attracted the attention
ofcytogeneticists. Its main features were increased spon-
taneous and induced chromosomal instability and a strik-
ing cancer proneness (8). These recessively inherited
"chromosomal instability syndromes," therefore, were
regarded as model diseases documenting the close rela-
tionship ofgenetic damage and malignant transformation
(9,10). Patients with those disorders may be regarded as
extreme variants of a possibly common interindividual
variability of genome stability and, thus, ofmutagen sus-
ceptibility (11).
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About 12 years ago, we published data on chromosomal
aberrations found in blood lymphocytes oftumor patients
undergoing a cytostatic interval therapy with methyl-
CCNU [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] flu-
ororacil, and vincristin (12). One of the most striking
findings of this study was the extreme interindividual
variation ofchromosomal response to an identical scheme
oftherapywith exactly comparable doses. With this vari-
ability in mind, we appreciated the hypothesis ofHsu (11)
that a close relation might exist between the genomic
instability ofan individual and his or her cancer risk. Ifa
variety ofmutational events actuallyplays such an impor-
tant role in the multistep process of malignant transfor-
mation, every factor increasing the number of those
events, for instance, a genetically determined individual
genomic instability, should also increase the individual
cancer risk. And even in those cases not showing an
increased spontaneous chromosomal instability, muta-
tional stress eventually could provoke an immanent muta-
gensusceptibility. Ifthese considerations arevalid, cancer
patients should be loaded by an increased genomic
instability which should express itself not only by an
increased spontaneous aberrationratebutalsobyahigher
sensitivity versus mutagenic influences than is found in
healthypersons ofthe averagepopulation. Severalreports
demonstrating an increased incidence of karyotypic
changes and spontaneous chromosomal breakage in non-
neoplastic somaticcells ofcancerpatients seemto supportGEBHART ET AL.
this view. As reviewed by Heim et al. (13), these findings,
however, were not too consistent; several authors did not
find anyincrease. In addition, manyofthese studieswere
deficientinanalyses ofcontrolgroupsanddidnotconsider
mutagen sensitivity.
Having been involved for many years in studies on the
cytogenetics of human solid tumors, we took the oppor-
tunity to obtain peripheral blood lymphocytes from a
group ofpatients with rectal tumors and to analyze their
chromosomal stability and mutagen sensitivity using
various techniques and end points: In addition to
karyotyping and determining the spontaneous frequency
of breakage and sister chromatid exchange (SCE), the
sensitivity of these cells to diepoxybutane (DEB),
4-nitroquinoline-1-oxide (NQO), and in a number ofcases
also to bleomycin was studied using chromosomal break-
age and SCE as end points.
Patients and Methods
Culturesofperipheralbloodlymphocytesobtainedfrom
33patientswith colorectal (in 32 casesrectal) cancer were
thebasis ofthis study (Table 1). Details ofthe cytogenetic
and oncogenetic data of the tumors have been published
elsewhere (14). In addition, control cultures were set up in
parallel from peripheral blood of 28 healthy individuals
selected by age and sex for controls.
In afirstpilotstudy, karyotypeanalysisusingstandard
GTGbandingwasperformedin15ofthesepatients aswell
as in a comparable control group of healthy individuals.
Spontaneouschromosomeaberrations wereanalyzedfrom
100 well-spread metaphases prepared from bromodeoxy-
uridine (BrdU)-labeled cultures of 28 patients and 28
control individuals. In addition, chromosomal sensitivity
to chemical mutagens/carcinogens was studied using a
lable 1. Data for the patients included in this study.
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Cytogenetics
pM abnormala
1 ND
1 ND
0 V
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0 II
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0 III
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Abbreviations: ND, no data available; L, I, U, lower, intermediate, or upper part of the rectum, respectively; pT, pN, pM, classification system of
clinical stagingofthe tumors (40) Theinternational stagingsystemofsolid tumors defines tumors according to theiranatomical extension: pTindexfor
tumor diameter and invasiveness [Ti: diameter lower than 2 cm, T2: diameter lower than 5 cm, T3: diameter over 5 cm; T4: infiltration ofneighboring
tissue]; pN index ofaffection ofregionallymph nodes [NO: no affection, Ni: affection ofhomolateral, N2: affection ofbi- and contralateral lymph nodes,
N3: fused nodi]; pM index ofdistant metastases [Ml: one distant metastasis, etc.].
aClassification system ofkaryotypic abnormalityofthetumorfromsingle abnormalities (I) toextremelycomplexkaryotypes (V), as defined in Rau et
al. (38).
blIPype of analysis performed in the present study: "all" means karyotyping + spontaneous breakage + exposure to DEB, NQO, and BLM; K =
karyotype only; SS = spontaneous stability; IS = sensitivity to inducing clastogens; -BLM = no bleomycin data.
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Table 2. Protocol for testing chromosomal instability.
Length of BrdU
treatment, Supplement,
Inducing hr before hr before
agent Standard dose sampling samplinge
None - - 48
DEB 0.01 ,ug/mL 24 24
NQO 0-5 mole/L 24 24
BLM(G1) 200 ,ug/mL 3 + 21 No
BLM (G2) 100 ,g/mL 2 No
Abbreviations: DEB, diepoxybutane; NQO, 4-nitroquinoline-1-oxide;
BLM, bleomycin.
aFinal concentration = 10-s M.
b3-hr treatment followed by 21-hr interval.
protocol developed in our laboratory for the analysis of
chromosomal instability syndromes (Table 2). Diepoxy-
butane and NQO were applied to lymphocytes of all
patients and control individuals; bleomycin was used only
in a limited number ofexperiments in the sense of a pilot
study.
At least 100 "first" metaphases per treatment and indi-
vidual were analyzed for chromosomal aberrations from
BrdU-labeled slides. Inaddition,in acoupleofpatientsand
controls, the SCE rate was estimated from at least 30
"second" metaphases. The Wilcoxon test was used to test
the differences between paired breakage rates.
Results
In a first pilot study, karyotype analyses were per-
formedinpartofthepatients and controls. Inthepatients'
lymphocytes, karyotypic changes were found about twice
as frequently as in the control lymphocytes. Hyper- and
hyposomy of the X-chromosome were clonally present in
the lymphocytes ofthree ofthe patients butin none ofthe
controls. Although other numerical changes were not
found in controls, the lymphocytes of one of the patients
showed clonal monosomies ofchromosomes 19, 21, and 22.
Among the clonal structural changes, inversions in chro-
mosome12and adeletioninthelong armofchromosome16
were found in clonal form in a few patients. Nonclonal
anomalies of other chromosomes were found in the
patients' lymphocytes, but less frequently in those of the
control individuals.
The spontaneous chromosomal instability was esti-
mated from BrdU-labeled first metaphases of 72-hr lym-
phocyte culures of 28 cancer patients and 28 control
individuals. The average breakage rate was slightly but
significantly(p<0.01)increasedinthepatients' group com-
pared tothe controls (Table3). Thevalues showed alarger
variation in the patients, nine of the samples exhibited
breakage rates that were distinctly increased over the
average level (Fig. 1). The exchange index was also higher
in the lymphocytes ofthe patients (0.19% versus 0.11% in
thecontrols).The averagespontaneousSCE frequencydid
notdifferbetweenboth groups (Fig. 1; Table 3). The direct
comparison of each patient with the respective control
individual revealed a higher breakage rate in 18 of the
patients and 4 of the controls, while in 6 cases identical
rates were found (Table 3). As bleomycin was proposed by
others (see above) as a standard clastogen for the detec-
tion of animmanentchromosomalinstability, apilot study
was initiated on our material using this cytostatic anti-
biotic. Gl- and G2-phase exposure was included in this
analysis (Fig. 2AB). In the G1 experiments (see Table 2),
lymphocytes of controls, on average, showed a higher
breakage rate, and only 2 out of 10 patients showed a
higher individual breakage rate than the respective con-
trol. It wasmainlythethree "highresponders" amongthe
control individuals who were responsible for the average
differences ofaberration rates between both groups.
In the G2 experiments, 7 out of 15 patients had higher
breakage rates, and the average breakage rate was
slightly increased in the patients' group (p<0.05). The
average exchange index of the patients was about twice
that of the controls. However, high responders were
detected in both the patient and control groups (Fig.
2A,B). As shown in Figure 2C, three patientswith familial
adenomatous polyposis did not have a higher response to
bleomycin than the controls studied in parallel.
Similar to the data on the spontaneous breakage
reported before, a slightbut significant (p<0.01) tendency
to increased rates of DEB-induced breakage was
Table 3. Comparison between the group ofpatients and ofcontrol individuals ofthe frequencies ofthe various end points studied on
lymphocyte cultures under different exposure conditions.
Patients vs.
% Aberrations No. per 100 metaphases Breaks/ controlsa
Exposure Group n Nm metaphase G' G" B' B" E metaphase + = - SCE/metaphase
Untreated Patients 28 3160 5.9 2.56 0.35 2.27 1.29 0.19 0.042 18 6 4 5.20
Controls 28 2980 5.0 2.65 0.53 1.47 0.79 0.11 0.026 4 6 18 5.05
BLM (Gl) Patients 10 1180 41.8 13.98 1.61 33.63 29.07 1.21 1.00 2 0 8 -
Controls 10 1020 56.3 23.14 2.45 55.39 58.23 1.74 1.53 8 0 2 -
DEB Patients 28 2940 9.4 4.28 0.78 4.25 2.14 0.41 0.074 17 6 5 12.93
Controls 28 2890 7.7 3.19 0.49 3.61 1.32 0.17 0.052 5 6 17 11.82
NQO Patients 27 2830 14.4 5.3 1.38 9.15 5.05 2.97 0.20 14 0 13 20.84
Controls 28 2900 14.3 4.3 1.17 7.21 3.79 3.14 0.18 13 0 14 20.23
Abbreviations: Nm, total number ofanalyzedmetaphases; G', chromatid gaps;G"t,isochromatid gaps,B', chromatidbreaks; B", isochromatid breaks;
E, exchanges; SCE, sister chromatid exchange; BLM, bleomycin; DEB, diepoxybutane; NQO, 4-nitroquinoline-1-oxide.
'Comparison ofbreakage rates ofindividual patients and theirparallel control: (+) breakage rate higherthan, (i=) breakage rate identical to, (-)
breakage rate lower than control.
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FIGURE 1. Individual spontaneous breakago
per metaphase in cultured blood lymphoc
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FIGURE 2. Bleomycin-induced breakage rates in culture
cytes from patients with rectal carcinomas (P) and fron
individuals (C) after exposurein G1 (A) andG2 (B). (C)br
3 patients with familial adenomatous polyposis. For ex
tocols see Table 2.
eM observed in the patients compared to controls. The SCE
rates, however, did not differ significantly between
patients' and controls' lymphocytes (Table 3). The lympho-
cytes of17 patients exhibited ahigherbreakage rate than
0 a those of the parallel controls, while, vice versa, this was
validforonly5ofthe28controls.Butonlyafewindividuals
* 0 were characterized by a breakage rate more distinctly 0 increased above average (Fig. 3). In addition, the average
exchangeindexinthepatientswasmorethantwicethatof
the controls (0.41% versus 0.17%). The addition of NQO
could not detect a significant difference between patients'
andcontrols as agroupinregardtoaveragebreakagerate
* (p>0.05)orinregardtotheSCEfrequencyinducedbythis
carcinogen (Table3). Sevenofthepatients andthree ofthe
controls, however, showed a high susceptibilityversus the
* ~ - chromosome-damaging effect of NQO (Fig. 4). As two of
P C the controls were loaded with a high number of NQO-
induced interchanges, the average exchange index did not
differ significantly between both groups.
Ie(left)andSCErates(right) A comparison of the data obtained from the various
lytes of patients with rectal exposure groups defined the chromosomes ofseven ofthe
patients and two of the control individuals as being
increasingly sensitive under more than one treatment
condition (Table 4). In three patients, all, spontaneous,
DEB-induced, and NQO-induced chromosomal breakage
wereincreased; twoofthesepatients,inaddition,showeda
B/M slightly increased bleomycin sensitivity. In three other
cases, the elevated spontaneous aberration ratewas asso-
ciated with sensitivity versus NQO. Interestingly, one
patient and one control individual, whose spontaneous
lymphocyte aberration rate was inconspicuous, proved to
be sensitive to both DEB and NQO.
Discussion
In accordance with several previous reports (15-23), a
slight spontaneous chromosomal instability and a slightly
increased chromosomal sensitivity to clastogens/
carcinogens could be detected in a group ofpatients with
rectal carcinoma. As these differences in the average
breakage ratesin all categorieswere stronglycausedbya
few "high responders," we do not believe that it would be
justified to regard increased chromosomal instability as a
feature ofthe whole group ofpatients with rectal cancer.
* In the G1 experiments with bleomycin, even more con-
trolindividuals than cancerpatientsproved tobesensitive
to the clastogenic action ofthis cytostatic drug. Thelatter
data, however, also should not be overestimated, as only
rather small numbers of patients and controls were
included in this pilot study on bleomycin.
There was, however, a series ofinvestigations reported
that did not find an increased chromosomal instability in
cancer patients (15,24-28). For the reasons pointed out
P C above, these observations also cannot bejudged to abso-
lutely disagree with our findings, as the majority of
patientswith rectal cancer, indeed, was notburdenedwith
ahbloodlympho- increased chromosomal instability or sensitivity to
-eakageratesfor clastogens. Reports on increased SCE frequencies in
'perimental pro- blood lymphocytes of cancer patients (29-33), however,
could not be confirmed by the present investigation.
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FIGURE 3. Diepoxybutane-induced breakage (left) and sister chromatid
exchange rates (right) in cultured lymphocytes from patients with rectal
carcinomas (P) and from healthy control individuals (C).
Table 4. Individuals with increased chromosomal instability
under more than one exposure condition.a
Increased breakage in
Code Untreated DEB-exposed NQO-exposed BLM-exposed
no. lymphocytes lymphocytes lymphocytes lymphocytes
64 - + + +
72 (+) - (+) +
117 + + - (+) -
121 + + ++ -
122 ++ - + + ND
127 + + + + + + +
132 ++ - ++ -
C113 + +± - ND
C124 - + ++ _
a+ + More than twice the average breakage rate; +, more than 1.5
times up to twice the average breakage rate; (+) 1.5 times or nearly 1.5
times the average breakage rate; -, not distinctly increased above the
average breakage rate; ND, no data.
FIGURE 4. 4-Nitroquinoline-1-oxide-induced breakage (left) and sister
chromatid exchange rates (right) in cultured lymphocytes from patients
with rectal carcinomas (P) and from healthy control individuals (C).
These differences in outcomes ofvarious investigations
may be due to a variety offactors. A critical review ofthe
respective literature (13,34) shows a strikinglack ofmeth-
odological consistency in many of the reports. We agree
with Heim et al. (13) that only those investigations should
be regarded as informative in which "appropriate control
populations have been included, and in which the com-
parisons have been made between groups that are large
enough for statistical analysis to be meaningful." But also
regarding these basic guidelines, differences of outcome
were evident. The studied cell type, therefore, must be
regarded as another reason for confounding results. As
most studies on somatic chromosomal instability were
performed onlymphocytes or, in afew cases onfibroblasts,
B/M
D.3
0.2
.
so
so
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and theneoplasms were carcinomas inmostcases, theuse
of inappropriate and therefore uninformative cells might
also explain some ofthese discrepancies.
Another important aspect may be the varying interac-
tion of genetic and environmental factors in the type of
respective cancer studied. Hsu (35), for instance, had
shown that, in patients with cancers ofthe colon or ofthe
lung the bleomycin-induced chromosomal instability in
noncancerous somatic cells was more distinctly expressed
than it was in breast cancer patients. In addition, cancer
riskmustnotnecessarilybe determinedbythepredispos-
inggenetic load ofthewhole organism, butcould ratherbe
due to amorelocaltissue-specific chromosomal instability
(repair incapability). Therefore, as shown above, analyses
restricted to one specific tissue, for instance, to lympho-
cytes of patients with cancers of other sites and tissues,
may lead to false conclusions. It is, therefore, a welcome
change that those cell systems derived from the most
common cancers are used more and more in experimental
mutagenicity testing (36,37).
Irrespective ofthese aspects, from amore generalview,
testing chromosomal breakage in peripheral blood lym-
phocytes of individuals exposed to environmental toxins
retains its importance as a monitoring system in genetic
toxicology because it nevertheless allows detection of
"high-risk individuals."
In the present study, as well as in several others, the
average aberration rates were strongly determined by a
group ofhigh responders. Some ofthe individuals ofthis
present investigation, in addition, showed chromosomal
instability evident under various exposure conditions.
These multiple responders, nevertheless, must be
regarded as belonging to a high-risk group and are possi-
bly cancer prone. The analysis ofthe cytogenetic findings
intumors frommultiple responders reveals thatfiveofthe
six multiple responders, for whom respective data were
available andtwoofthehighresponders in oneexperiment
belonged to the category with the highest level of
karyotypic anomalies in the tumor cells (14,38).
Therefore, apart from being generally suited to detect
predisposition to cancer, cytogenetic screening evidently
can detect high-risk individuals. Screening needs to be
further investigated by prospective studies (39) to deter-
mine if correlation or association actually exists between
increased chromosomal instability or mutagen sensitivity
and human disease, in particular, cancer.
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